Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
1244 results
-
ATAGI update following weekly COVID-19 meeting – 12 May 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 12 May 2021. -
2021-22 Budget investment for medical research
The Australian Government has announced an investment of $2.6 billion over the next four years for the Medical Research Future Fund (MRFF) in the 2021-22 Federal Budget. This continued investment will help drive innovation, improve health outcomes, and create jobs. -
Budget 2021–22 information
Health Budget 2021–22 information is now available. -
Budget delivers $17.7 billion for once in a generation change to aged care in Australia
A $17.7 billion reform package will provide higher quality and safer care for senior Australians. -
Budget’s historic $2.3 billion investment in mental health and suicide prevention
The Australian Government is investing $2.3 billion in the National Mental Health and Suicide Prevention Plan – the largest Commonwealth mental health investment in Australia’s history. -
Should you take blood thinning medication before having the AstraZeneca vaccine?
Find accurate, evidence-based answers to questions about COVID-19 vaccines, including whether you should take blood thinning medication before having the AstraZeneca vaccine. -
Australian Technical Advisory Group on Immunisation (ATAGI) weekly COVID-19 meeting on 4 May 2021 update
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 4 May 2021 -
Vaccinations now available for people 50 years and over
The next phase of Australia's COVID-19 vaccination rollout has commenced. -
ATAGI update following weekly COVID-19 meeting – 28 April 2021
An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 28 April 2021 -
Review of the Guiding principles for medication management in residential aged care facilities and in the community
The Australian Commission on Safety and Quality in Health Carewill lead a review and update of the guiding principles for medication management in residential aged care facilities and in the community to support the safe and quality use of medicines. -
ATAGI reinforce recommendations on use of COVID-19 vaccines following review of vaccine safety data and benefits
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on use of COVID-19 vaccines following review of vaccine safety data and benefits. -
National Cabinet update from the Prime Minister
The Prime Minister provides an update from today's National Cabinet meeting where the COVID-19 vaccination program was discussed. Find out more. -
COVID-19 Vaccination Program – National Cabinet update on 22 April 2021
A presentation with an update on Australia's COVID-19 vaccine rollout is now available to view or download. -
Medicare Benefits Schedule Electrocardiogram Review Committee – appointment of Committee Members
The Medicare Benefits Schedule (MBS) Review Committee was established in March 2021 to review electrocardiogram (ECG) items introduced on 1 August 2020, following recommendations from the MBS Review Taskforce. -
Australian Health Protection Principal Committee (AHPPC) statement on continuous learning in managed quarantine for international arrivals
A statement from the Australian Health Protection Principal Committee (AHPPC) on continuous learning in managed quarantine for international arrivals. -
New advice on AstraZeneca vaccine
There have been changes to the advice around the COVID-19 vaccines. The Pfizer vaccine is now preferred to the AstraZeneca vaccine for adults aged under 50 years. -
Joint statement on AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns
Professor Brendan Murphy, Department of Health Secretary and Professor Paul Kelly, Australian Government Chief Medical Officer have released a joint statement about ATAGI's latest clinical advice on the AstraZeneca vaccine. -
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in response to new vaccine safety concerns. -
ATAGI statement on COVID-19 vaccination and a reported case of thrombosis
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on COVID-19 vaccination and a reported case of thrombosis. -
ATAGI statement for consumers on a specific clotting condition being reported after COVID-19 vaccination
A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) for consumers on a specific clotting condition being reported after COVID-19 vaccination -
2021 NIP influenza vaccination program
Influenza vaccines through the National Immunisation Program (NIP) became available in April 2021. Timing may be different for your local area. You can order vaccines through the usual channels in your state or territory. -
Flu vaccination in 2021
Vaccination against influenza (flu) remains important this year. Flu is a highly contagious viral infection that can cause widespread illness and deaths every year. Vaccination is our best defence against flu viruses. -
Public release for 2020 Health Employee Census Results
The Australian Public Service employee census report for 2020 has been released. Read more about the census and Health's results. -
Flood information and support
The floods affecting New South Wales and Queensland can also impact our health in many ways. Learn more on how you can access medical help you need, and what the Australian Government is doing to support your health during this time. -
$3.2 million to take medical devices from discovery to manufacture
The Australian Government is providing $3.2 million for the fourth and final round of the $45 million BioMed Tech Horizons program. This program has been successful in bringing cutting edge medical devices to market.